Evaluation of the effectiveness of complementary therapy with ninjinyoueito in the perioperative phase of pulmonary resection - Trial UMIN000047863

Name: Clinical Trial UMIN000047863
Creator: Higashi-Hiroshima Medical Center, National Hospital Organization (Clinical Research Department)
Keywords: Lung cancer, drug, clinical trial, Japan

Access comprehensive clinical trial information for UMIN000047863 through Pure Global AI's free database. This phase not specified trial is sponsored by Higashi-Hiroshima Medical Center, National Hospital Organization (Clinical Research Department) and is currently Completed. The study focuses on Lung cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

UMIN000047863

Completed

drug

Trial Details

University Hospital Medical Information Network • UMIN000047863

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Evaluation of the effectiveness of complementary therapy with ninjinyoueito in the perioperative phase of pulmonary resection

Study Focus

Disease/Condition

Lung cancer

Study Type

Interventional

Intervention Type

drug

Sponsor & Location

Primary Sponsor

Higashi-Hiroshima Medical Center, National Hospital Organization (Clinical Research Department)

Location

Japan

Timeline & Enrollment

Phase

N/A

Start Date

Sep 07, 2020

End Date

N/A

ICD-10 Classifications

Carcinoma in situ: Bronchus and lung

Secondary malignant neoplasm of lung

Malignant neoplasm of bronchus and lung

Malignant neoplasm: Bronchus or lung, unspecified

Malignant neoplasm: Overlapping lesion of bronchus and lung

Data Source

Registry

University Hospital Medical Information Network

Trial ID

UMIN000047863

Type

Non-Device Trial